Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Chentai New Materials | 2024 | Series A | $13.7M | Suzhou |
| 35Pharma | 2024 | Series C | $53.0M | Montreal |
| Harmony Biosciences | 2024 | Post Ipo Secondary | $248.0M | Plymouth Meeting |
| Ventyx Biosciences | 2024 | Post Ipo Equity | $27.0M | San Diego |
| Serán Bioscience | 2024 | Private Equity | $200.0M | Bend |
| Lepu Bio | 2024 | Post Ipo Equity | $29.4M | Shanghai |
| Ajax Therapeutics | 2024 | Series C | $95.0M | Cambridge |
| Clasp Therapeutics | 2024 | Series A | $150.0M | Cambridge |
| ASLAN Pharmaceuticals | 2024 | Post Ipo Equity | $5.0M | Singapore |
| Attralus | 2024 | Series B | $56.0M | San Francisco |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 51 | Chentai New Materials | Series A | $13.7M | Suzhou, China |
| 52 | 35Pharma | Series C | $53.0M | Montreal, Canada |
| 53 | Harmony Biosciences | Post Ipo Secondary | $248.0M | Plymouth Meeting, United States |
| 54 | Ventyx Biosciences | Post Ipo Equity | $27.0M | San Diego, United States |
| 55 | Serán Bioscience | Private Equity | $200.0M | Bend, United States |
| 56 | Lepu Bio | Post Ipo Equity | $29.4M | Shanghai, China |
| 57 | Ajax Therapeutics | Series C | $95.0M | Cambridge, United States |
| 58 | Clasp Therapeutics | Series A | $150.0M | Cambridge, United States |
| 59 | ASLAN Pharmaceuticals | Post Ipo Equity | $5.0M | Singapore, Singapore |
| 60 | Attralus | Series B | $56.0M | San Francisco, United States |
Chentai New Materials integrates the R&D, design, manufacturing, and sales of high-performance composite ceramics.
35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need.
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.
Serán Bioscience is a contract development and manufacturing organization.
Lepu Bio is a Innovation-Driven Biopharmaceutical Company offering unmet medical needs of cancer patients with best-in-class drugs.
Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.
Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system.
ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.
Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.
Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.
Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.
EsoBiotec is a Belgian biotechnology business focused on the discovery of novel cancer therapies.
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.
Ossium Health builds a bone marrow bank to treat blood cancers.
Ocelot Bio brings new treatment options to patients with severe liver disease.
IGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer.
OCI develops therapies for leukaemia based on CAR–T.
Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.
Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.
Immune-Onc Therapeutics is a newly established biopharmaceutical company that develops therapeutic antibodies for cancer treatment.
Pulmobiotics is a pre-clinical life sciences company.
Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.
Vivo Capital has invested in 105 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Vivo Capital's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Biopharma. The firm invests across 17 different industry categories.
Among tracked funding rounds, Legend Biotech received $350.0M in a Post Ipo Equity round. Vivo Capital's total known invested capital is $5.6B.
Vivo Capital's average investment size is $78.6M across its portfolio of 105 companies.
Recent Vivo Capital portfolio additions include Chentai New Materials, 35Pharma, Harmony Biosciences, Ventyx Biosciences, Serán Bioscience. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors